ManchesterStory Group
VC Fund
West Des Moines, United States
ManchesterStory Group is an early-to-growth stage venture capital firm focused on InsurTech, FinTech, and HealthTech sector. It was founded by Dave Miles and Matt Kinley in 2017 and is based in West Des Moines, Iowa, United States.
- Total investments:
- 53
- Last investment:
- Lead investor:
- 51%
- Fund size:
- $81M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries ManchesterStory Group invests in
Stages ManchesterStory Group invests in
Countries ManchesterStory Group invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $2M–$7.5M
- Series A
- $4M–$18M
- Series B
- $24M–$100M
Investment Focus
Industry
- Insurance 21 (40%)
- InsurTech 13 (25%)
- Financial Services 10 (19%)
- Health Care 9 (17%)
- FinTech 8 (15%)
Stage
- Series A 24 (45%)
- Seed 15 (28%)
- Series B 3 (6%)
- Venture - Series Unknown 3 (6%)
- Series C 2 (4%)
Country
- United States 31 (58%)
- Canada 3 (6%)
- Mexico 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
David Miles
Founding Partner
|
Founding Partner | Total investments: 6 | Find email | |
Matt Kinley
Managing Partner
|
Managing Partner | Total investments: 12 | Find email | |
Jason Gross
Vice President and Head of Platform
|
Vice President and Head of Platform | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Xcaliber provides a digital health platform that automates healthcare data tasks using AI agents. The platform supports integration across various healthcare systems, including EHRs, APIs, and clinical data. It offers agents for data management, workflow automation, and compliance tasks, with customizable options for different healthcare needs. Theplatform ensures secure data access, governance, and traceability while supporting both technical and non-technical teams through APIs and natural language interfaces. | $6.5M / Seed / May 05, 2026 | ||
| Flora Fertility is dedicated to empowering the next generation of parents by putting the control of reproductive health outcomes back where they belongs—in your hands. It aims to revolutionize how women's health and family building are approached, making fertility care more accessible, transparent, and personalized. By reimagining thefinancial and medical aspects of family planning, we help you navigate the journey to parenthood with greater confidence, ease, and support, ensuring that your fertility choices align with your personal goals and circumstances. | $5M / Seed / Apr 07, 2026 | ||
| When Insurance is a technology platform that helps individuals and employers navigate health insurance options during transitions such as job loss or retirement. It connects users with a marketplace of health plans from third-party providers and offers tools to compare and apply for coverage alternatives to COBRA, including personalized guidanceand reimbursement options for premiums. The platform integrates with HR systems to support workforce offboarding, provides concierge support from licensed advisors, and assists with Medicare navigation and healthcare reimbursement benefits. When Insurance operates as an intermediary facilitating access to health insurance choices rather than selling insurance directly. | $10.2M / Series A / Jan 30, 2026 | ||
| Salvo is emerging as the leader in helping GI providers leap into a hybrid-care vision of the future of medicine, providing brick & mortar clinics with an easy to implement continuous care platform that saves time, increases revenue and improves patient outcomes.The company has announced agreements with 771 GI’s, representing 15% of allindependent GI’s in the US, to deploy wraparound care for their clinic patients. Included in its customers are five of the largest GI practices in the country, together seeing over 1.1 million GI patients a year. Salvo provides the tech and care delivery for modern, interdisciplinary care to treat chronic conditions that have surged in cost and prevalence: --IBS and IBD (over 40M affected) -- GERD and Celiac (over 50M affected) --MASH/MASLD, what was previously called “fatty liver disease” (over 80M) --Obesity (over 100M) The care benefits patients (76% of patients reported improved symptoms, five accepted medical conference abstracts on outcomes), generates incremental profit for practices (over $2M EBITDA improvement for a 100 GI practice), and reduces total healthcare costs (79% drop in GI-related ER utilization). | $8.5M / Series A / Jan 22, 2026 | ||
| Penguin AI uses AI to analyze health records and support care decisions, improving patient outcomes. | $25M / Series A / Sep 11, 2025 | ||
| Journey is a simple meditation practice designed for the modern world, providing on-demand and live-streamed meditation courses.Journey was created to share meditation in a way that all people could relate to, wherever they are in life. It has created a simple yet powerful technique that could appeal to a large-scale audience, changing a lot ofpeople’s lives. It takes a step beyond meditation by introducing six simple yet powerful Life Lessons.Founded in 2015 by Stephen Sokoler, Journey Meditation is headquartered in New York. | $8M / Series A / Jul 25, 2025 | ||
| Stitch Studio is focused on transforming insurance operations through AI-powered solutions. The Stitch Studio approach leverages advanced AI to streamline processes, enhance productivity, and empower teams to focus on high-value tasks. | $3M / Seed / Apr 01, 2025 | ||
| Founded and advised by a team of world-renowned insurance, finance, and technology industry veterans with a passion for transparent and unbiased advice, COVU's mission is to help everyday people and growth-oriented insurance professionals reduce risk and manage insurance smarter.COVU’s holistic approach ensures agencies thrive by managingthe business side of insurance operations to provide an extraordinary customer experience through a unique combination of AI technology, human intelligence, real-time service, and top-tier sales support. | $12.5M / Series A / Oct 10, 2024 | ||
| XP Health is a health tech startup introducing a new kind of vision benefit for employees leveraging machine learning.Founded in 2019 by Antonio Moraes and James Wong, XP Health is an AI-powered vision benefits platform for employees and their families to get frames from the world’s leading designers like Tom Ford, Ray-Ban, Armani, Gucci, Coach.Its proprietary deep learning model uses facial recognition technology that recommends the best frames based on facial dimensions with 98% accuracy. The company is working with companies like Chegg, Zenefits, and Sequoia Consulting Group. | $33.2M / Series B / Sep 12, 2024 | ||
| Rainwalk is a pet insurance MGA partnered with Allianz. We help insurers build retention and fill this coverage gap by providing them a turn-key white labeled pet insurance product. Our platform allows our partners to control the user/agent experience and deliver this increasingly popular product without needing to implement a pet insuranceprogram themselves. Rainwalk is founded by two insurance professionals who have spent their entire careers working with the largest carriers on their digital transformation and technology projects. Rainwalk combines its proprietary policy and claims management technology stack with the pet insurance product expertise of Allianz to deliver service across the entire insurance life cycle.Long term we will use our established distribution channels and our partnership with Allianz to identify and scale other emerging insurance products in the US market that are ready to achieve meaningful premium at scale. | $4M / Seed / Apr 23, 2024 | ||
| See all 53 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does ManchesterStory Group invest in?
ManchesterStory Group invests primarily in Insurance, InsurTech and Financial Services startups, most often at Series A and Seed stage. Most of the 53 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is ManchesterStory Group's check size?
ManchesterStory Group typically joins rounds of $2M–$7.5M at Seed, $4M–$18M at Series A and $24M–$100M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds ManchesterStory Group participates in.
How do I contact ManchesterStory Group?
Public channels for ManchesterStory Group include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at ManchesterStory Group?
The team at ManchesterStory Group includes David Miles (Founding Partner), Matt Kinley (Managing Partner) and Jason Gross (Vice President and Head of Platform). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
